Unique Wealth LLC Acquires 1,775 Shares of Stryker Co. (NYSE:SYK)

Unique Wealth LLC lifted its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 26.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,598 shares of the medical technology company's stock after acquiring an additional 1,775 shares during the quarter. Unique Wealth LLC's holdings in Stryker were worth $3,201,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in Stryker during the 4th quarter worth approximately $25,000. Capital A Wealth Management LLC acquired a new stake in Stryker during the 4th quarter worth approximately $26,000. Rakuten Securities Inc. lifted its holdings in Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC acquired a new stake in Stryker during the 4th quarter worth approximately $30,000. Finally, BankPlus Trust Department acquired a new stake in Stryker during the 4th quarter worth approximately $33,000. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 5.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

SYK has been the subject of several research reports. JMP Securities reissued a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Truist Financial lifted their price objective on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. Roth Mkm lifted their price objective on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a report on Friday, May 2nd. Finally, BTIG Research set a $403.00 price objective on Stryker and gave the company a "buy" rating in a report on Monday, April 14th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Stryker currently has an average rating of "Moderate Buy" and an average price target of $427.30.

Stryker Trading Up 0.0%

Shares of SYK opened at $382.74 on Friday. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19. The business's fifty day moving average is $369.88 and its 200-day moving average is $376.06. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The firm has a market cap of $146.09 billion, a price-to-earnings ratio of 49.32, a PEG ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The company's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter last year, the company posted $2.50 EPS. Equities analysts anticipate that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. Stryker's dividend payout ratio is currently 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.